Trimauxil Overview

  • Founded
  • 2015
  • Status
  • Private
  • Employees
  • 9
  • Latest Deal Type
  • Angel
  • (Cancelled)
  • Investors
  • 1

Trimauxil General Information


Developer of a weight-loss nutritional supplement for pets. The company develops a weight-loss supplement designed for dogs to reduce their body weight and improve immunity.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Food Products
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 747 South West 2nd Avenue
  • IMB Suite 18
  • Gainesville, FL 32601
  • United States
+1 (904) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Trimauxil Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Angel (individual) 17-Aug-2017 Cancelled Startup
2. Accelerator/Incubator 01-Dec-2015 Completed Startup
1. Grant 17-Nov-2015 $7K Completed Startup
To view Trimauxil’s complete valuation and funding history, request access »

Trimauxil Executive Team (3)

Name Title Board Seat Contact Info
Albert Fosmoe Founder, Board Member & Chief Executive Officer
Paul Hassie Chief Financial Officer
Beth Eckenrode Chief Commercial Officer
To view Trimauxil’s complete executive team members history, request access »

Trimauxil Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Trimauxil Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
GAINnet Other 000 0000 000000 0
To view Trimauxil’s complete investors history, request access »